WRITTEN ANALYSIS OF THE CASE BETA COMPANY SYNOPSIS Beta Company produces two Product A and B and standard costs of each product were predetermined by management. During November actual production for Product A was 4,200 units while Product B was 3,600 units. For material X, 39,000 pounds were purchased at $14.40 and for material Y, 11,000 pounds were purchased at $9.70. Variance analysis for actual cost versus standard cost should be prepared for the said month to be able to measure results
Words: 846 - Pages: 4
Written Case Analysis Background: Beta Company is a manufacturing company that produces two products, A and B. Problem Statement: To compute the actual cost of each product, compare the result to the standard and interpret the same using variance analysis. Answers and Interpretation: |1 |Material Price Variance (Material X)= |$23,400.00 |F |Material X |$14,400.00 | | |Material Price Variance (Material Y)=
Words: 585 - Pages: 3
I. STATEMENT OF THE PROBLEM Beta Company produces two products, A and B, Each of which uses materials X and Y. The Following unit Standard cost apply: Material X Material Y Direct Labor Product A 4 lbs @ $15 1 lb @ $9.50 1/5 hr @ $18 Product B 6 lbs @ $15 2 lbs @ $9.50 1/3 hr @ $18 During November 4,200 units of A and 3,600 units of B were produced. Also, 39,000 pounds of X were purchased at $14.40, and 11,000 pounds of Y were purchased at $9.70; all of these materials (but no other
Words: 1085 - Pages: 5
October 1, 2012 Case Study#6: Beta Management Company In 1988, Sarah Wolfe formed and became the CEO of an investment management company named Beta Management Company in the Boston metro area. It was primarily created due to the results of the October 1987 market crash when a rich married couple was saddened by their investment losses. In early 1991, Ms. Wolfe was pondering whether or not to initiate a plan to set out new objectives and guidelines for Beta in the upcoming year. Currently, Beta’s
Words: 830 - Pages: 4
| Beta Management Company Case Report | | Full name: Student ID: Class Time: Lecturer's Name: | Table of Contents I.Case background 2 II.Sarah Wolfe 2 III.Background of California R.E.I.T. and Brown Group, Inc. 3 IV.Return and risk 4 V.Summarize in bullet points what you learn from your case analysis. 7 VI.Appendix 8 I. Case background Who: Sarah Wolfe who is the founder and also the CEO of Beta Management Company Where: Small investment companies near a suburb of Boston
Words: 1935 - Pages: 8
Beta-blockers xxxx Collin College HPRS 1310-WW1 April 15, 2012 The first beta-blocker drug approved by the FDA in 1967 was developed by Sir James Black, an accomplishment for which he was awarded the Nobel Prize in Medicine in 1988 (Stapleton, 1997). Sir Black took a different approach to the treatment of angina pectoris—instead of using drugs to increase the amount of oxygen delivered to the heart, Black sought to find a drug that could reduce the amount of oxygen required by the heart.
Words: 1215 - Pages: 5
Am J Stem Cell 2012;1(3):196-204 www.AJSC.us /ISSN:2160-4150/AJSC1208001 Review Article Directed differentiation of progenitor cells towards an islet-cell phenotype Arif Abed1, Charlotte Critchlow2, Peter R Flatt3, Neville H McClenaghan3, Catriona Kelly1 The Guy Hilton Research Centre, Institute for Science and Technology, Keele University, UK; 2Keele Medical School, Keele University, UK; 3Diabetes Research Group, SAAD Centre for Pharmacy and Diabetes, University of Ulster, Coleraine, UK 1
Words: 5231 - Pages: 21
Discusión Se le llama glucemia a la glucosa que está en la sangre, tiene que encontrarse 5mm en la sangre para que un paciente este normal. La insulina es una hormona que se secreta en el páncreas exactamente en los islotes de Langerhans por su factor beta, esto ocurre cuando a través del Glut 2 membranal los detectores de glucosa encuentran una concentración más alta a lo necesario Esta hormona (la insulina) viaja por el torrente sanguíneo y afecta las células hepáticas, neuronales y musculares
Words: 315 - Pages: 2
542 學術 阿茲海默失智症的食療科學證據 文/孫 瑜 邱銘章* 李明濱** 恩主公醫院神經內科 台大醫院神經內科* 台灣失智症協會理事長** 背 景 阿茲海默失智症為一逐漸腦部退化以致於喪失智 能的疾病，包括喪失智力與生活能力，年紀愈大，愈 易得病，這是現在人口結構逐漸老化的社會，必須面 對的重要議題。長久以來，就有不少研究在探討飲食 與失智症的相關性，包括食物種類與得病的相關性， 及以飲食型態來預防或延緩疾病惡化。這些飲食的研 究中，有不少建議攝取富含維他命C、E及胡蘿蔔素等 抗氧化食物來預防或改善失智症的惡化，另外維他命 B群、葉酸，不飽合脂肪酸、魚類、酒類等，都曾被 報導過可降低阿茲海默失智症的風險。不過上述這些 研究的結論常常不一致。另外，臺灣很流行的保健食 品如紅麴及銀杏也被奉為預防失智症的聖品，還有現 在很熱門的地中海飲食，這些食物對阿茲海默失智症 的預防及治療效果的科學證據仍須進一步探討。本篇 研究擬以實證醫學的方法探討飲食對失智症的防治效 果，進而希望為高齡族群提供飲食的建議。 方 法 分兩階段進行。第一階段：先以一般性回顧的方
Words: 1824 - Pages: 8
in the Surgical Care Improvement Project (SCIP) Inf-2, after May a significant decrease in compliance is noted. Use of prophylactic antibiotics prior to incision (SCIP Inf-1), stopping the antibiotic within 24 hrs. of surgery end time (SCIP Inf-3), beta blockers given during perioperative period (SCIP Card-2), recommended VTE prophylaxis ordered (SCIP VTE-1) and given within 24 hrs. prior through 24 hrs. after surgery (SCIP VTE-2) Corrective Action Plan The goal of the prophylactic antibiotic
Words: 883 - Pages: 4
